Chennai, India

Venkatasubramanian Hariharan


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkatasubramanian Hariharan: Innovator in Pharmaceutical Chemistry

Introduction: Venkatasubramanian Hariharan is a notable inventor based in Chennai, India. With a focused career in pharmaceutical development, he has made significant contributions to the field through his innovative research and patents. His work primarily deals with novel derivatives that have important pharmaceutical applications.

Latest Patents: Venkatasubramanian Hariharan holds a patent for "2-substituted methyl penam derivatives." This invention presents a new class of compounds that include various chemical forms such as tautomers, stereoisomers, and polymorphs. These derivatives are characterized by specific chemical structures where A can be either carbon or nitrogen, and encompass a range of substituents that are critical for their pharmaceutical activity.

Career Highlights: Currently, Venkatasubramanian is employed at Orchid Chemicals & Pharmaceuticals Limited. His work at the company has been pivotal in developing innovative pharmaceutical solutions that enhance treatment options in healthcare. He is recognized for his meticulous research approach and commitment to advancing medical science through innovation.

Collaborations: Throughout his career, Venkatasubramanian has collaborated with prominent individuals in the field, including his coworkers Senthilkumar Udayampalayam Palanisamy and Andrew Gnanaprakasam. These collaborations have enriched his research and enabled the launch of impactful pharmaceutical products.

Conclusion: Venkatasubramanian Hariharan exemplifies the spirit of innovation within the pharmaceutical industry. His patented work on 2-substituted methyl penam derivatives not only showcases his expertise but also contributes valuable advancements to medical science. As he continues his work with Orchid Chemicals & Pharmaceuticals Limited, the future looks promising for further innovations that could improve healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…